Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) EBIT Margin: 2009-2019

Historic EBIT Margin for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2019 value amounting to 9.17%.

  • Neurocrine Biosciences' EBIT Margin rose 3217.00% to 15.03% in Q3 2021 from the same period last year, while for Sep 2021 it was 8.84%, marking a year-over-year decrease of 460.00%. This contributed to the annual value of 9.17% for FY2019, which is 99.00% up from last year.
  • Neurocrine Biosciences' EBIT Margin amounted to 9.17% in FY2019, which was up 12.16% from 8.18% recorded in FY2018.
  • Neurocrine Biosciences' 5-year EBIT Margin high stood at 9.17% for FY2019, and its period low was -982.48% during FY2016.
  • Over the past 3 years, Neurocrine Biosciences' median EBIT Margin value was 8.18% (recorded in 2018), while the average stood at -286.13%.
  • In the last 5 years, Neurocrine Biosciences' EBIT Margin tumbled by 50,671bps in 2016 and then skyrocketed by 88,392bps in 2018.
  • Neurocrine Biosciences' EBIT Margin (Yearly) stood at -475.77% in 2015, then crashed by 50,671bps to -982.48% in 2016, then spiked by 10,674bps to -875.74% in 2017, then spiked by 88,392bps to 8.18% in 2018, then soared by 99bps to 9.17% in 2019.